|
1
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen W, Song M, Liu J, Qiu G, Li T, Hu Y
and Liu H: MiR-26a promotes ovarian cancer proliferation and
tumorigenesis. PLoS One. 9:e868712014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang H, Wang Q, Zhao Q and Di W: MiR-124
inhibits the migration and invasion of ovarian cancer cells by
targeting SphK1. J Ovarian Res. 6:842013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tung CS, Wong KK and Mok SC: Biomarker
discovery in ovarian cancer. Womens Health (Lond Engl). 4:27–40.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen D, Zhang Y, Wang J, Chen J, Yang C,
Cai K, Wang X, Shi F and Dou J: MicroRNA-200c overexpression
inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian
cancer stem cells by regulating epithelial-mesenchymal transition.
J Ovarian Res. 6:502013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Kim S and Kim IM: Regulation of
metastasis by microRNAs in ovarian cancer. Front Oncol. 4:1432014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song L, Liu D, Wang B, He J, Zhang S, Dai
Z, Ma X and Wang X: miR-494 suppresses the progression of breast
cancer in vitro by targeting CXCR4 through the Wnt/β-catenin
signaling pathway. Oncol Rep. 34:525–531. 2015.PubMed/NCBI
|
|
10
|
Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q,
Wei Q, Li X, Wang J and Zeng H: MicroRNA-494-3p targets CXCR4 to
suppress the proliferation, invasion, and migration of prostate
cancer. Prostate. 74:756–767. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim WK, Park M, Kim YK, Tae YK, Yang HK,
Lee JM and Kim H: MicroRNA-494 downregulates KIT and inhibits
gastrointestinal stromal tumor cell proliferation. Clin Cancer Res.
17:7584–7594. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohdaira H, Sekiguchi M, Miyata K and
Yoshida K: MicroRNA-494 suppresses cell proliferation and induces
senescence in A549 lung cancer cells. Cell Prolif. 45:32–38. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Asuthkar S, Velpula KK, Nalla AK, Gogineni
VR, Gondi CS and Rao JS: Irradiation-induced angiogenesis is
associated with an MMP-9-miR-494-syndecan-1 regulatory loop in
medulloblastoma cells. Oncogene. 33:1922–1933. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kwak SY, Yang JS, Kim BY, Bae IH and Han
YH: Ionizing radiation-inducible miR-494 promotes glioma cell
invasion through EGFR stabilization by targeting p190B rhoGAP.
Biochim Biophys Acta. 1843:508–516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lim L, Balakrishnan A, Huskey N, Jones KD,
Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, et al:
MicroRNA-494 within an oncogenic microRNA megacluster regulates
G1/S transition in liver tumorigenesis through suppression of
mutated in colorectal cancer. Hepatology. 59:202–215. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak and Schmittgen: Analysis of relative
gene expression data using real-time quantitative PCR and the
2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Webb PM: Environmental (nongenetic)
factors in gynecological cancers: Update and future perspectives.
Future Oncol. 11:295–307. 2015. View Article : Google Scholar
|
|
18
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bartels CL and Tsongalis GJ: MicroRNAs:
Novel biomarkers for human cancer. Ann Biol Clin (Paris).
68:263–272. 2010.(In French). PubMed/NCBI
|
|
21
|
Yamanaka S, Campbell NR, An F, Kuo SC,
Potter JJ, Mezey E, Maitra A and Selaru FM: Coordinated effects of
microRNA-494 induce G2/M arrest in human
cholangiocarcinoma. Cell Cycle. 11:2729–2738. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Libório-Kimura TN, Jung HM and Chan EK:
miR-494 represses HOXA10 expression and inhibits cell proliferation
in oral cancer. Oral Oncol. 51:151–157. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang R, Chen X, Zhang S, Zhang X, Li T,
Liu Z, Wang J, Zang W, Wang Y, Du Y and Zhao G: Upregulation of
miR-494 inhibits cell growth and invasion and induces cell
apoptosis by targeting cleft lip and palate transmembrane 1-like in
esophageal squamous cell carcinoma. Dig Dis Sci. 60:1247–1255.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He W, Li Y, Chen X, Lu L, Tang B, Wang Z,
Pan Y, Cai S, He Y and Ke Z: miR-494 acts as an anti-oncogene in
gastric carcinoma by targeting c-myc. J Gastroenterol Hepatol.
29:1427–1434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ries J, Vairaktaris E, Agaimy A, Kintopp
R, Baran C, Neukam FW and Nkenke E: miR-186, miR-3651 and miR-494:
Potential biomarkers for oral squamous cell carcinoma extracted
from whole blood. Oncol Rep. 31:1429–1436. 2014.PubMed/NCBI
|
|
26
|
Duan H, Jiang Y, Zhang H and Wu Y: MiR-320
and miR-494 affect cell cycles of primary murine bronchial
epithelial cells exposed to benzo[a]pyrene. Toxicol In Vitro.
24:928–935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim YW, Kim EY, Jeon D, Liu JL, Kim HS,
Choi JW and Ahn WS: Differential microRNA expression signatures and
cell type-specific association with Taxol resistance in ovarian
cancer cells. Drug Des Devel Ther. 8:293–314. 2014.PubMed/NCBI
|
|
28
|
Yuan J, Wang K and Xi M: miR-494 inhibits
epithelial ovarian cancer growth by targeting c-Myc. Med Sci Monit.
22:617–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li XT, Wang HZ, Wu ZW, Yang TQ, Zhao ZH,
Chen GL, Xie XS, Li B, Wei YX, Huang YL, et al: miR-494-3p
Regulates Cellular proliferation, invasion, migration, and
apoptosis by PTEN/AKT signaling in human glioblastoma cells. Cell
Mol Neurobiol. 35:679–687. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Romano G, Acunzo M, Garofalo M, Di Leva G,
Cascione L, Zanca C, Bolon B, Condorelli G and Croce CM: MiR-494 is
regulated by ERK1/2 and modulates TRAIL-induced apoptosis in
non-small-cell lung cancer through BIM down-regulation. Proc Natl
Acad Sci USA. 109:16570–16575. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang X, Zhang X, Ren XP, Chen J, Liu H,
Yang J, Medvedovic M, Hu Z and Fan GC: MicroRNA-494 targeting both
proapoptotic and antiapoptotic proteins protects against
ischemia/reperfusion-induced cardiac injury. Circulation.
122:1308–1318. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amann T, Bataille F, Spruss T, Dettmer K,
Wild P, Liedtke C, Mühlbauer M, Kiefer P, Oefner PJ, Trautwein C,
et al: Reduced expression of fibroblast growth factor receptor
2IIIb in hepatocellular carcinoma induces a more aggressive growth.
Am J Pathol. 176:1433–1442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liang J, Chen P, Hu Z, Zhou X, Chen L, Li
M, Wang Y, Tang J, Wang H and Shen H: Genetic variants in
fibroblast growth factor receptor 2 (FGFR2) contribute to
susceptibility of breast cancer in Chinese women. Carcinogenesis.
29:2341–2346. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Matsuda Y, Ueda J and Ishiwata T:
Fibroblast growth factor receptor 2: Expression, roles, and
potential as a novel molecular target for colorectal cancer.
Patholog Res Int. 2012:5747682012.PubMed/NCBI
|
|
35
|
Cole C, Lau S, Backen A, Clamp A, Rushton
G, Dive C, Hodgkinson C, McVey R, Kitchener H and Jayson GC:
Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in
ovarian cancer. Cancer Biol Ther. 10:495–504. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tannheimer SL, Rehemtulla A and Ethier SP:
Characterization of fibroblast growth factor receptor 2
overexpression in the human breast cancer cell line SUM-52PE.
Breast Cancer Res. 2:311–320. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yasumoto H, Matsubara A, Mutaguchi K, Usui
T and McKeehan WL: Restoration of fibroblast growth factor
receptor2 suppresses growth and tumorigenicity of malignant human
prostate carcinoma PC-3 cells. Prostate. 61:236–242. 2004.
View Article : Google Scholar : PubMed/NCBI
|
